Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (471-480 of 759) with videos related to

Pageof 76
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2016
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal GammopathiesLarissa S Higgins, Ronald S Go, David Dingli, et al.
Bone Marrow Transplantation|November 4, 2018
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Cancer Research|April 6, 2007
Molecular dissection of hyperdiploid multiple myeloma by gene expression profilingWee J Chng, Shaji Kumar, Scott Vanwier, et al.
American Journal of Hematology|November 13, 2014
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosisGregory P Kaufman, Angela Dispenzieri, Morie A Gertz, et al.
EJNMMI Research|October 29, 2017
Safety, pharmacokinetics, metabolism and radiation dosimetry of <sup>18</sup>F-tetrafluoroborate (<sup>18</sup>F-TFB) in healthy human subjectsHuailei Jiang, Nicholas R Schmit, Alex R Koenen, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple MyelomaSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Cancer Genetics and Cytogenetics|January 22, 2002
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progressionRoelandt F J Schop, Syed M Jalal, Scott A Van Wier, et al.
Mayo Clinic Proceedings|February 7, 2021
Coagulation Abnormalities in Light Chain AmyloidosisNadine Abdallah, Eli Muchtar, Angela Dispenzieri, et al.
Leukemia & Lymphoma|August 20, 2005
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphomaYinlee Yoong, Luis F Porrata, David J Inwards, et al.
Bone Marrow Transplantation|April 10, 2019
Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal functionM Hasib Sidiqi, Kalyan Nadiminti, Abdullah S Al Saleh, et al.
Pageof 76

Showing results (471-480 of 759) with videos related to

Sort By:
Pageof 76
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2016
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal GammopathiesLarissa S Higgins, Ronald S Go, David Dingli, et al.
Bone Marrow Transplantation|November 4, 2018
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Cancer Research|April 6, 2007
Molecular dissection of hyperdiploid multiple myeloma by gene expression profilingWee J Chng, Shaji Kumar, Scott Vanwier, et al.
American Journal of Hematology|November 13, 2014
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosisGregory P Kaufman, Angela Dispenzieri, Morie A Gertz, et al.
EJNMMI Research|October 29, 2017
Safety, pharmacokinetics, metabolism and radiation dosimetry of <sup>18</sup>F-tetrafluoroborate (<sup>18</sup>F-TFB) in healthy human subjectsHuailei Jiang, Nicholas R Schmit, Alex R Koenen, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple MyelomaSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Cancer Genetics and Cytogenetics|January 22, 2002
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progressionRoelandt F J Schop, Syed M Jalal, Scott A Van Wier, et al.
Mayo Clinic Proceedings|February 7, 2021
Coagulation Abnormalities in Light Chain AmyloidosisNadine Abdallah, Eli Muchtar, Angela Dispenzieri, et al.
Leukemia & Lymphoma|August 20, 2005
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphomaYinlee Yoong, Luis F Porrata, David J Inwards, et al.
Bone Marrow Transplantation|April 10, 2019
Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal functionM Hasib Sidiqi, Kalyan Nadiminti, Abdullah S Al Saleh, et al.
Pageof 76